Follicular Lymphoma Microenvironment Characteristics Associated with Tumor Cell Mutations and MHC Class II Expression
Authors:
- Guangchun HanGHGuangchun Han
- Qing DengQDQing Deng
- Mario L. Marques-PiubelliMMMario L. Marques-Piubelli
- Enyu DaiEDEnyu Dai
- Minghao DangMDMinghao Dang
- Man Chun John MaMMMan Chun John Ma
- Xubin LiXLXubin Li
- Haopeng YangHYHaopeng Yang
- Jared HendersonJHJared Henderson
- Olga KudryashovaOKOlga Kudryashova
- Mark MeersonMMMark Meerson
- Sergey IsaevSISergey Isaev
Top Cited Papers
Open Access
- 10 June 2022
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Blood Cancer Discovery
- Vol. 3 (5) , 428-443
Abstract
Follicular lymphoma (FL) is a B-cell malignancy with a complex tumor microenvironment that is rich in nonmalignant immune cells. We applied single-cell RNA sequencing to characterize the diverse tumor and immune cell populations of FL and identified major phenotypic subsets of FL T cells, including a cytotoxic CD4 T-cell population. We characterized four major FL subtypes with differential representation or relative depletion of distinct T-cell subsets. By integrating exome sequencing, we observed that somatic mutations are associated with, but not definitive for, reduced MHC expression on FL cells. In turn, expression of MHCII genes by FL cells was associated with significant differences in the proportions and targetable immunophenotypic characteristics of T cells. This provides a classification framework of the FL microenvironment in association with FL genotypes and MHC expression, and informs different potential immunotherapeutic strategies based upon tumor cell MHCII expression. Significance: We have characterized the FL-infiltrating T cells, identified cytotoxic CD4 T cells as an important component that is associated with tumor cell–intrinsic characteristics, and identified sets of targetable immune checkpoints on T cells that differed from FLs with normal versus low MHC expression. See related commentary by Melnick, p. 374. This article is highlighted in the In This Issue feature, p. 369Keywords
All Related Versions
Funding Information
- National Cancer Institute (R01CA201380)
- Leukemia and Lymphoma Society (1372-21)
- Leukemia and Lymphoma Society
This publication has 69 references indexed in Scilit:
- Depleting tumor-specific Tregs at a single site eradicates disseminated tumorsJournal of Clinical Investigation, 2013
- IgBLAST: an immunoglobulin variable domain sequence analysis toolNucleic Acids Research, 2013
- GSVA: gene set variation analysis for microarray and RNA-Seq dataBMC Bioinformatics, 2013
- Pathogenesis of follicular lymphomaJournal of Clinical Investigation, 2012
- Induction of tumoricidal function in CD4+ T cells is associated with concomitant memory and terminally differentiated phenotypeJournal of Experimental Medicine, 2012
- VarScan 2: Somatic mutation and copy number alteration discovery in cancer by exome sequencingGenome Research, 2012
- Combined Genetic Inactivation of β2-Microglobulin and CD58 Reveals Frequent Escape from Immune Recognition in Diffuse Large B Cell LymphomaCancer Cell, 2011
- The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing dataGenome Research, 2010
- Targeted capture and massively parallel sequencing of 12 human exomesNature, 2009
- Follicular lymphomas with and without translocation t(14;18) differ in gene expression profiles and genetic alterationsBlood, 2009